Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics

Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics

Biff F Palmer,1 Amy D Rock,2 Emily J Woodward2 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, 2Department of Research and Development, Cumberland Pharmaceuticals Inc., Nashville, TN, USA Purpose: This study aimed to evaluate the efficacy, safety...

Full description

Bibliographic Details
Main Authors: Palmer BF, Rock AD, Woodward EJ
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:Drug Design, Development and Therapy
Subjects:
critical care
electrolyte
SIADH
V2 receptor antagonist
thiazide
osmotic demyelination syndrome
Online Access:https://www.dovepress.com/dose-comparison-of-conivaptan-vaprisolreg-in-patients-with-euvolemic-o-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/dose-comparison-of-conivaptan-vaprisolreg-in-patients-with-euvolemic-o-peer-reviewed-article-DDDT

Similar Items